Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN

Schlichtig K, Lechner P, Grafe C, Ferstl B, Fuchs F, Hein A, Meidenbauer N, Sell C, Semrau S, Pavel ME, Wullich B, Neurath M, Fietkau R, Beckmann M, Mackensen A, Fromm M, Dorje F, Siebler J (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 41

Pages Range: 198-198

Authors with CRIS profile

Katja Schlichtig Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie Carolin Grafe Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie Alexander Hein Department of Obstetrics and Gynaecology Marianne Ellen Pavel Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Bernd Wullich Lehrstuhl für Urologie Markus Neurath Lehrstuhl für Innere Medizin I Rainer Fietkau Lehrstuhl für Strahlentherapie Matthias Beckmann Lehrstuhl für Geburtshilfe und Frauenheilkunde Andreas Mackensen Lehrstuhl für Innere Medizin V Martin Fromm Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie Jürgen Siebler Professur für Hepatologie

How to cite

APA:

Schlichtig, K., Lechner, P., Grafe, C., Ferstl, B., Fuchs, F., Hein, A.,... Siebler, J. (2018). Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN. (pp. 198-198).

MLA:

Schlichtig, Katja, et al. "Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN." 2018. 198-198.

BibTeX: Download